Metraipolis › archive › dc_bfef8b1174f7
Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer — Europe PMC PMID:41454718
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41454718
- DOI
- 10.1002/advs.202513086
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T09:14:15.698Z
- SHA-256 of the archived text
626652c93c5eadbdf3a0647e75d8861be0973075f0f28ce38804edfb23f731c5- Stable URL of this page
https://metraipolis.com/documento/dc_bfef8b1174f7
How to cite
Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer — Europe PMC PMID:41454718 — Europe PMC (en), https://europepmc.org/article/MED/41454718 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfef8b1174f7 (Metraipolis archive dc_bfef8b1174f7, sha256 626652c93c5eadbdf3a0647e75d8861be0973075f0f28ce38804edfb23f731c5)
BibTeX
@misc{dcbfef8b1174f7,
title = {Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer — Europe PMC PMID:41454718},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41454718},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfef8b1174f7; sha256 626652c93c5eadbdf3a0647e75d8861be0973075f0f28ce38804edfb23f731c5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41454718. Agents can read the archived copy with the MCP tool read_document.